Company / Cash per Share
BIOCRYST PHARMACEUTICALS INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.41
FY2025
5-year range
$0.41 / $2.82
FY2021-FY2025
Trend
-19.0%
vs FY2024
Sector context
#181 of 205
Health Care
What the data says
BIOCRYST PHARMACEUTICALS INC's cash per share of $0.41 is lower than 88% of companies in the Health Care sector (FY2025). Cash per Share has declined for 4 consecutive years, from $2.82 in FY2021 to $0.41 in FY2025.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of -24.1%.
Declined from $0.58 to $0.41 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -37.0%
- 5-Year CAGR
- -24.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 205This company $0.41 Sector average $67.98
▼
-99.4% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's cash per share has declined for 4 consecutive years.
- In FY2025, cash per share decreased 19.0% year-over-year.
- Ranks #181 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | -19.0% |
| FY2024 | $0.51 | -12.0% |
| FY2023 | $0.58 | -64.9% |
| FY2022 | $1.64 | -41.8% |
| FY2021 | $2.82 | +73.1% |
| FY2020 | $1.63 | +64.7% |
| FY2019 | $0.99 | +281.2% |
| FY2018 | $0.26 | -62.0% |
| FY2017 | $0.68 | +126.2% |
| FY2016 | $0.30 | -25.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026